Balchem Inc. (BCPC) - Price-to-Projected Revenue Ratio

Balchem - graphic logo of issuer BCPC

Strong pricing power in chemicals and inelastic demand for feed contrast with the current lull in the agricultural sector, although drivers in medicine are still developing. The change in the forward P/S ratio demonstrates the dynamics of the scalability premium, where 4.70 determines the current value of the indicator. Growth is based on a scientific approach to nutrient microencapsulation, which enhances farm productivity and human health for Balchem Corporation (BCPC).

Balchem - BCPC Market Cap to Future Revenue Ratio (period 07/04/2022 - 11/14/2026)

BCPC (Balchem Inc.): analytical breakdowns and indicator data

- stock price and consensus target price:
Stock Quotes Balchem|BCPC - Fair Value Consensus
- market capitalization indicators:
Market Value Balchem Inc.|BCPC - Value Adjusted for Debt and Cash
- book value of equity indicators:
Book Value per Share Balchem|BCPC - Total Stockholders' Equity|Market Value to Book Value Ratio balchem.com|BCPC - Company Total Asset Base
- debt and solvency information:
Debt to Equity Balchem Corporation|BCPC - Long-Term Liabilities to Capital|Short-Term Debt to Equity Ratio Balchem Corporation|BCPC - Company Aggregate Debts|Debt to Book Capitalization Ratio Balchem Inc.|BCPC - Company Long-Term Loans and Borrowings|Company Short-Term Debts Balchem|Quick Ratio balchem.com
- financial results and valuation multiples details:
BCPC - Company Net Income|Expected Profit Balchem Corporation|BCPC - Business Payback Period|Forward P/E Multiple Balchem Corp.|BCPC - Price/Earnings to Growth Ratio|EV/EBITDA Multiple Balchem Inc.|BCPC - Operating profit EBITDA|Earnings per share for the last twelve months Balchem|BCPC - Earnings per share for the last twelve months|Quarterly EPS earnings growth balchem.com|BCPC - Net earnings per share growth this year|Earnings growth forecast for next year Balchem Corporation
- revenue and sales details:
BCPC - Company Sales Revenue|Projected Sales Volume Balchem|BCPC - Price to Sales|Price-to-Projected Revenue Ratio Balchem Inc.
Fundamental company analysis:BCPC (Balchem)
Original product of balchem.com

When screening the reliability of Balchem Corporation (BCPC), investors evaluate the forward P/S ratio, which compares current market capitalization with projected revenue to identify whether the business is overvalued or undervalued. The current value of 4.70 reflects market expectations regarding the implementation of AI automation in ingredient synthesis, while the projected P/S trend allows for the rapid identification of asset value anomalies relative to the pace of technological deployment.

Key competitors

Corteva - Forward Price-to-Revenue Multiple|Forward Price to Sales NTR|CF - Price-to-Projected Revenue Ratio|Forward Price to Sales MOS (Mosaic Co.)|ELAN: Forward P/S Multiple|Market Cap to Future Revenue Ratio FMC Corp (FMC)|Price-to-Projected Revenue Ratio The Scotts Miracle-Gro Company|Phibro Animal Health Corp (PAHC) - Market Cap to Expected Sales Ratio|Price-to-Projected Revenue Ratio CVR Partners Corp (UAN)|ODC - Market Cap to Future Revenue Ratio|Intrepid Potash, Inc. - Forward Price-to-Revenue Multiple|Forward P/S Multiple lavoroagro.com LVRO|AVD - Price-to-Projected Revenue Ratio|Forward Price to Sales GRO (Brazil Potash Corp)|ICCC: Forward P/S Multiple|Forward Price-to-Revenue Multiple Enlightify Corporation|SEED (Origin Agritech Ltd.) - Forward P/S Multiple|Market Cap to Future Revenue Ratio cgagri.com CGA|Price-to-Projected Revenue Ratio S&W Seed Co. (SANW)